Keywords: emea, agrees, strategy, spectrum, eoquin, cancer, drug

EMEA agrees strategy for Spectrum's EOquin

Article | 14 January 2008

Print This

US cancer drug specialist Spectrum Pharmaceuticals has received notice from the European Medicines Agency (EMEA) that it agrees with the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in